ATMP Introductory lectures

The basics of the ATMP field from what are ATMPs to the issues in reimbursing their use

These lectures are being offered as part of the ATMP Sweden/Karolinska Institutet run “Gene and Cell Therapy Product (ATMP) Drug Development” PhD course.

Registration through ATMP  Sweden 2020 -now closed.

PROGRAM ATMP Introductory Lectures – November 16th – 20th, 2020.

Monday 16th November 

ATMP technology and classification 

9:30 – 10:15 – What are ATMPs and historyKarin Hoogendoorn presentation on request

10:15 – 11:00 – Entering the manufacture environment – Heather Main

presentation slides: Entering the manufacturing environment 161120

The ATMP drug development chain 

13:00 – 14:00 – Evren Alici (KI/NextGenNK)

Tuesday 17th November 

Manufacturing of ATMP from an academic´s point of view

9:00 – 9:40 – Adaptation of a research product to GMP – Regulatory and quality aspects of manufacturing and planning a future clinical trial. Lilian Walther Jallow, PhD, research coordinator, KI and CEO, BOOST Pharma

presentation slides: phd kurs_manufactuingslides

9:45 – 10.15 – The Manufacturer´s perspective; what to do and what to avoid – Ulrica Eistrand, PhD, Production Manager, Vecura

presentation slides: Requirements for GMP-production process_20201115

Wednesday 18th November 

ATMP/GMP manufacture 

9:00-9:40 Introduction to ATMPs in Sweden and ATMP manufacturingPontus Blomberg (Vecura/KCC, CAMP)

presentation slides: Pontus lecture GMP manufacture 20201118

9:40-10:00 Scale up and scale outMichael Chrobok (KI pre-GMP)

presentation slides: Scaling up Scaling out Michael Chrobok

Thursday 19th November 

Commercial considerations for ATMP

9:00 – 9:45 Opportunities and Challenges in Cell Therapies – Johan Hyllner presentation on request

10:00 – 10:45 Commercial considerations in ATMP – Dag Larsson presentation on request

11:00 – 11:45 Ethical aspects in commercialisation of human tissue – Mats Hansson 

Ethical aspects ATMP20201119